Can Glimepiride reduce the progression of diabetic neuropathy? What evidence supports its role in slowing nerve damage or alleviating symptoms?
Share
Sign Up to our social questions and Answers Engine to ask questions, answer people’s questions, and connect with other people.
Please briefly explain why you feel this question should be reported.
Please briefly explain why you feel this answer should be reported.
Please briefly explain why you feel this user should be reported.
Glimepiride primarily manages blood sugar levels in type 2 diabetes but does not directly target diabetic neuropathy. There is limited evidence suggesting it reduces nerve damage progression.